Loree M. Larratt

5.1k citations
87 papers · 4.2k · 1 hit paper · h-index 33

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments

Papers in

    • Acute Myeloid Leukemia Research 24
    • Hematopoietic Stem Cell Transplantation 23
    • Chronic Myeloid Leukemia Treatments 7
    • Chronic Lymphocytic Leukemia Research 23

Loree M. Larratt

85 papers receiving 4.0k citations

Loree M. Larratt's Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial 2018 · 469 citations
4690+2+5Years since publication100200300400

Peers

Loree M. Larratt
Comparison fields: 5 of 95
  • Genetics 1.7k
  • Hematology 1.3k
  • Pathology and Forensic Medicine 1.1k
  • Immunology 1.0k
  • Transplantation 82
Replace Wolfgang Ulrich Knauf with:
Wolfgang Ulrich Knauf Germany
Daniela Damiani Italy
KC Anderson United States
Aleksander B. Skotnicki Poland
Anders Österborg Sweden
Laurence Elias United States
Lugui Qiu China
Aristeidis Chaidos United Kingdom
Peter Gimsing Denmark
Kazimierz Kuliczkowski Poland
Loree M. Larratt relative to Wolfgang Ulrich Knauf Germany Wolfgang Ulrich Knauf's profile →
Citations per field
00.5×2×3.4×
Wolfgang Ulrich Knauf · 1×
Citations per year

Countries citing papers authored by Loree M. Larratt

Since Specialization
Citations

This map shows the geographic impact of Loree M. Larratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loree M. Larratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loree M. Larratt more than expected).

Fields of papers citing papers by Loree M. Larratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loree M. Larratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loree M. Larratt. The network helps show where Loree M. Larratt may publish in the future.

Co-authors

The 25 scholars most cited alongside Loree M. Larratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Loree M. Larratt Line = papers co-authored together Loree M. Larratt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2018469
2 2010409
3 2003324
4 2007247
5 2016199
6 2018199
7
Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.
1984163
8 2005148
9 2009142
10 1984114
11 2020110
12 2013109
13 2022100
14 199772
15 200769
16
Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation.
199665
17 200564
18 200764
19 200258
20 200858

About Loree M. Larratt

Loree M. Larratt is a scholar working on Hematology, Genetics, Immunology, Public Health, Environmental and Occupational Health and Oncology, having authored 87 papers that have together received 4.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Chronic Lymphocytic Leukemia Research (23 papers), Hematopoietic Stem Cell Transplantation (23 papers), Acute Lymphoblastic Leukemia research (18 papers), Lymphoma Diagnosis and Treatment (10 papers), Complement system in diseases (9 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). The work is most often cited by research in Genetics (1.7k citations), Hematology (1.3k citations), Pathology and Forensic Medicine (1.1k citations), Immunology (1.0k citations) and Transplantation (82 citations). Loree M. Larratt has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Andrew R. Belch, Michael J. Mant, Tony Reiman, Jonathan J. Keats, Brian John Taylor, Christopher A. Maxwell, Linda M. Pilarski, A. Robert Turner, John G. Gribben and Benjamín Koziner. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Bone Marrow Transplantation, Leukemia Research and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact